INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo POLYTAR LIQUID

SCHEDULING STATUS:
Unscheduled

PROPRIETARY NAME
(and dosage form):

POLYTAR LIQUID

(Medicated Scalp Cleanser - Shampoo)

COMPOSITION:
Active Ingredient : Polytar 1,0 g/100 g 
Comprising : Coal tar solution 0,1%
    Juniper Tar (Cade oil) 0,3%
    Pine Tar (Tar) 0,73%
    Arachis oil extract of coal tar 0,03%
Preservative : Imidurea 0,50 g/100 g 
PHARMACOLOGICAL CLASSIFICATION:
A13.9.1

PHARMACOLOGICAL ACTION:
Polytar Liquid is concentrated, antiseptic, tar-medicated scalp cleanser adjusted to a pH of 5,5. It contains 1% Polytar as the active ingredient. Coal tar preparations have been used extensively for over 50 years in the management of various skin disorders, especially psoriasis and eczema. The precise mechanism of action of the tars is uncertain - all have some keratolytic, antipruritic and antiseptic action.

INDICATIONS:
Polytar Liquid is indicated in the treatment of scalp disorders such as psoriasis, dandruff, seborrhoeic dermatitis, eczema and pruritus. Polytar Liquid is also of value in the removal of ointments and pastes used in the treatment of psoriasis.

CONTRA-INDICATIONS:
Nil

WARNINGS
Nil

DOSAGE AND DIRECTIONS FOR USE:
The hair should be wetted and sufficient Polytar Liquid applied to produce an abundant lather. The scalp and adjacent areas should be vigorously massaged with the fingertips. The hair should then be thoroughly rinsed and the procedure repeated.
Polytar Liquid should be used once or twice weekly.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Experience of many years of marketing has shown that the incidence of adverse reactions to Polytar Liquid is less than one percent. These reactions of erythema, dryness, contact dermatitis, irritation and acne-like eruptions are mild and of very low incidence.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
No specific symptoms can be expected from excessive topical use of the product.
Ingestion may cause nausea and vomiting. Following ingestion, induce vomiting if large quantities (greater than 250 mL) have been swallowed.
Administer copious quantities of water and antacids as required.

CONDITIONS OF REGISTRATION:
None

IDENTIFICATION:
Clear, brownish liquid.

PRESENTATION:
Bronze, oval high density polyethylene bottles of 65 mL, 150 mL or 350 mL capacity with white caps. The bottles are printed on directly with white ink.

STORAGE INSTRUCTIONS:
Store below 30°C
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
G2050 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Stiefel Laboratories (SA) Pty. Limited
20 Julbert Road, Benrose,
Johannesburg

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
January 1990

EF58

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998